Evidence map›Paper›PMID 40066228›Full record

ArticleMedComm2025

Xuebing Yan, Xiao Qu, Jiaxin Wang, Ling Lu, Wenjuan Wu, Jingxian Mao, Donglin Li, Ying Wang, Qing Wei, Jianqiang Liu

Abstract read
In one paragraph

Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Gut microbiota in health and disease.Molecular biomedicine · 2026
    Review
  2. Article
  3. Article
  4. Fujita medical journal · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. [Gut microbiota involved in cancer invasion and metastasis].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuebing YanDepartment of Oncology Affiliated Hospital of Yangzhou University Yangzhou China.
Xiao QuDepartment of General Surgery The First Affiliated Hospital of USTC Hefei China.
Jiaxin WangDepartment of Oncology Affiliated Hospital of Yangzhou University Yangzhou China.
Ling LuDepartment of Laboratory Diagnostics Changhai Hospital Navy Military Medical University Shanghai China.
Wenjuan WuDepartment of Oncology Northern Jiangsu People's Hospital affiliated to Yangzhou University Yangzhou China.
Jingxian MaoDepartment of Oncology Affiliated Hospital of Yangzhou University Yangzhou China.
Donglin LiDepartment of Oncology Affiliated Hospital of Yangzhou University Yangzhou China.
Ying WangDepartment of Oncology Affiliated Hospital of Yangzhou University Yangzhou China.
Qing WeiDepartment of Pathology Shanghai Tenth People's Hospital Tongji University Shanghai China.
Jianqiang LiuDepartment of Endoscopy Fudan University Shanghai Cancer Center Shanghai China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gut microbiota and integrins are known to contribute to colorectal cancer (CRC), but whether they interact has been unclear. Here, we provided evidence that

Indexed as

calcium signalingcolorectal cancerFusobacterium nucleatumintegrin α5

Identifiers

PMID40066228
PMCPMC11892016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.